Last $0.64 USD
Change Today -0.0153 / -2.34%
Volume 143.9K
BONE On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 11:04 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John P. Gandolfo CPA

Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary, Bacterin International Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

53$525,347
As of Fiscal Year 2013

Background*

Mr. John P. Gandolfo, CPA has been the Chief Financial Officer of Bacterin International Holdings, Inc. since July 6, 2010, serves as its Treasurer and Secretary and also served as its Interim Co-Chief Executive Officer from April 5, 2013 to August 2013. Mr. Gandolfo serves as the Chief Financial Officer of Amorcyte Inc., which has a strategic partnership with Progenitor Cell Therapy. He served as the Interim Chief Financial Officer at Bacterin International Holdings, ...

Read Full Background

Corporate Headquarters*

600 Cruiser Lane
Belgrade, Montana 59714

United States

Phone: 406-388-0480
Fax: 406-388-0422

Board Members Memberships*

Former Chief Financial Officer, Principal Accounting Officer, Vice President of Finance, Director and Member of Ad-Hoc Financing Committee
2013-2013
Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary

Education*

Unknown/Other Education
Rutgers, The State University of New Jersey
BA
Rutgers, The State University of New Jersey

Other Affiliations*

Annual Compensation*

Salary$321,462
Bonus$100,800
Total Annual Compensation$422,262

Stock Options*

Restricted Stock Awards$68,340
Exercisable Options164,000
Total Number of Options390,000

Total Compensation*

Total Annual Cash Compensation$422,262
Total Short Term Compensation$422,262
Other Long Term Compensation$68,340
Total Calculated Compensation$525,347
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BONE:US $0.64 USD -0.0153

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William C. Mills IIIChairman of the Board, Chief Executive Officer and Chairman of Strategy & Technology Committee
Stereotaxis Inc.
$370.9K
Howard Zauberman Chief Executive Officer, President and Director
Vision-Sciences Inc.
$210.9K
Jeffrey M. Nugent Chief Executive Officer, Director and Member of Finance Committee
BIOLASE, Inc.
--
Robert E. Kill Chairman, Chief Executive Officer and President
Uroplasty, Inc.
$589.2K
Bernard A. Hausen M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Chief Medical Officer and Director
Cardica Inc.
$381.3K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BACTERIN INTERNATIONAL HOLDI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.